Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation

References

• Alexis F, Venkatraman SS, Rath SK, Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Contr Rel 2004; 98: 67–74
   PubMed Web of Science ®Google Scholar
• Aoki J, Ong ATL, Abizaid A, Tien Heijer P, Bonnier H, McClean DR, Verheye S, Belardi J, Condado JA, Pieper M, Sousa JE, Bressers M, Symons J, Litvack F, Sianos G, Serruys PW. One-year clinical outcome of various doses and pharmacokinetic release of paclitaxel eluted from an erodable polymer: Insight from the paclitaxel in-stent controlled elution study (PISCES). EuroIntervention 2005; 1: 165–172
   PubMedGoogle Scholar
• Burt HM, Hunter WL. Drug-eluting stents: A multidisciplinary success story. Adv Drug Deliv Rev 2006; 58: 350–357
   PubMed Web of Science ®Google Scholar
• Chen M-C, Liang H-F, Chiu Y-L, Chang Y, Wei H-J, Sung H-W. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J Contr Rel 2005; 108: 178–189
   PubMed Web of Science ®Google Scholar
• Chorny M, Fishbein I, Golomb G. Drug delivery systems for the treatment of restenosis. Crit Rev Ther Drug Carrier Syst 2000; 17: 249–284
   PubMed Web of Science ®Google Scholar
• Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788–794
   PubMed Web of Science ®Google Scholar
• Cook S, Togni M, Walpoth N, Maier W, Muehlberger V, Legrand V, Milicic D, Zambartas C, Zelizko M, Madsen JK, Van Buuren F, Lopez-Palop R, Peeba M, Koskenkorva J, Vanhanen H, Lablanche J-M, Lazaris I, Geza F, Eyjolfsson K, Kearney P, Piscione F, Erglis A, Navickas R, Beissel J, Channam R, Koch K, Deleanu D, Melberg T, Witkowski A, Pereira H, Reho I, Fridrich V, Zorman D, Nilsson T, Oezmen F, Ludman P, Meier B. Percutaneous coronary interventions in Europe 1992–2003. Euro Intervention 2006; 1: 374–379
   Google Scholar
• Daemen J, Serruys PW. Drug-eluting stent update 2007. Part II: Unsettled issues. Circulation 2007; 116: 961–968
   PubMed Web of Science ®Google Scholar
• Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003; 361: 247–249
   PubMed Web of Science ®Google Scholar
• Finn AV, Joner M, Nakazawa G, Kotodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435–2441
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500–1510
   PubMed Web of Science ®Google Scholar
• Grech ED. Pathopysiology and investigation of coronary artery disease. ABC of Interventional Cardiology. BMJ Publishing Group, London 2003; 1–6
   Google Scholar
• Grube E, Sonoda S, Ikeno F, Honda Y, Kar S, Chan C, Gerckens U, Lansky AJ, Fitzgerald PJ. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 2004; 109: 2168–2171
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov/cder/guidance.htm. Guidance for industry: Dissolution testing for immediate release solid oral dosage forms CDER. USA: FDA; 1997
   Google Scholar
• Hunter WL. Drug-eluting stents: Beyond the hyperbole. Adv Drug Deliv Rev 2006; 58: 347–349
   PubMed Web of Science ®Google Scholar
• Jackson JK, Smith J, Letchford K, Babiuk KA, Machan L, Signore P, Hunter WL, Wang K, Burt HM. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. Int J Pharm 2004; 283: 97–109
   PubMed Web of Science ®Google Scholar
• Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202
   PubMed Web of Science ®Google Scholar
• Khan IA, Patravale VB. The intra-vascular stent as a site-specific local drug delivery system. Drug Dev Ind Pharm 2005; 31: 59–78
   PubMed Web of Science ®Google Scholar
• Kutryk MJB, Serruys PW. Stents: The menu. Textbook of interventional cardiology, EJ Topol. Saunders, Philadelphia 2003; 591–630
   Google Scholar
• Lee CH, Lim J, Low A, Zhang XL, Kyaing TT, Chan MY, Wong HB, Lim YT, Tan HC. Sirolimus eluting, bioabsorbable polymer-coated constant stent (Cura) in acute ST-elevation myocardial infarction: A clinical and angiographic study (CURAMI Registry). J Invasive Cardiol 2007; 19: 182–185
   PubMedGoogle Scholar
• Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808–816
   PubMed Web of Science ®Google Scholar
• Mauri L, Hsieh W-H, Massaro JM, Ho KKL, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020–1029
   PubMed Web of Science ®Google Scholar
• Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-in-human study of the endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I trial. EuroIntervention 2005; 1: 157–164
   PubMedGoogle Scholar
• Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnár F, Falotico R. The RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–1780
   PubMed Web of Science ®Google Scholar
• Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175–181
   PubMed Web of Science ®Google Scholar
• Nuutinen J-P, Clerc C, Reinikainen R, Tormala P. Mechanical properties and in vitro degradation of bioabsorbable self-expanding braided stents. J Biomater Sci Polymer Edn 2003; 14: 255–266
   PubMed Web of Science ®Google Scholar
• Ong AT, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW. Sirolimus-eluting stents remain superior to bare-metal stents at two years: Medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2006; 47: 1356–1360
   PubMed Web of Science ®Google Scholar
• Padera RF, Schoen FJ. Cardiovascular medical devices. Biomaterials science, Ratner BD. Elsevier Academic Press, California 2004; 472–494
   Google Scholar
• Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly (D, L-lactide-co-glycolide) nano- and microparticles. J Contr Rel 2003; 92: 173–187
   PubMed Web of Science ®Google Scholar
• Rajagopaland V, Rockson SG. Coronary restenosis: A review of mechanisms and management. Am J Med 2003; 115: 547–553
   PubMedGoogle Scholar
• Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorli P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics—2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69–e171
   PubMed Web of Science ®Google Scholar
• Sarısözen C, Çalış S, Arıca B, Hıncal AA. Development of prednisolone acetate incorporated microspheres by spray-drying technique. Proceedings of the 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, 27–30 March, 2006
   Google Scholar
• Siewert M, Dressman J, Brown CK, Shah VP. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 2003; 4: 80
   Google Scholar
• Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention—executive summary. Circulation 2001; 103: 3019–3041
   PubMed Web of Science ®Google Scholar
• Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology drug-eluting stents: Part II. Circulation 2003; 107: 2383–2389
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME. TAXUS V investigators. Comparison of a polymer based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005; 294: 1215–1223
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998–1008
   PubMed Web of Science ®Google Scholar
• Tanabe K, Regar E, Lee CH, Hoye A, van der Giessen W, Serruys PW. Local drug delivery using coated stents: New developments and future perspectives. Curr Pharm Des 2004; 10: 357–367
   PubMed Web of Science ®Google Scholar
• Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, Nakamura T, Fujita S, Takeda S, Motohara S, Uehata H. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Interv 2003; 5: 13–16
   PubMedGoogle Scholar
• Unger F, Westedt U, Hanefeld P, Wombacher R, Zimmermann S, Greiner A, Ausborn M, Kissel T. Poly(ethylene carbonate): A thermoelastic and biodegradable biomaterial for drug eluting stent coatings?. J Contr Rel 2007; 117: 312–321
   PubMedGoogle Scholar
• van der Hoeven BL, Pires NM, Warda HM, Oemrawsingh PV, van Vlijmen BJ, Quax PH, Schalij MJ, van der Wall EE, Jukema JW. Drug-eluting stents: Results, promises and problems. Int J Cardiol 2005; 99: 9–17
   PubMed Web of Science ®Google Scholar
• Venkatraman S, Poh TL, Vinalia T, Mak KH, Boey F. Collapse pressures of biodegradable stents. Biomaterials 2003; 24: 2105–2111
   PubMed Web of Science ®Google Scholar
• Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004; 25: 1330–1340
   PubMed Web of Science ®Google Scholar
• Wang X. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials 2006; 27: 5588–5595
   PubMed Web of Science ®Google Scholar
• Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schäller S, Bakowsky U, Kissel T. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Contr Rel 2007; 119: 41–51
   PubMed Web of Science ®Google Scholar